Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-10-24
2000-10-03
Guzo, David
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
436 71, 436829, 536 231, 536 245, A61K 9127, C07H 2104
Patent
active
061269654
ABSTRACT:
It is possible to radiosensitize tumor cells by administration of compositions containing the Human antisense c-raf-1 oligodeoxyribonucleotide (ODN/oligo) sequence: 5'-GTGCTCCATTGATGC-3' (seq. #1) wherein only the end bases are phosphorylated is a preferred embodiment. Antisense sequences of up to 40 bases which containing this sequence may be used in accord with the teachings of this disclosure. Compositions comprising a cationic liposome of dimethyldioctadecyl ammonium bromide, phosphatidylcholine and cholesterol may be used as a carrier system. The liposomes provide a new carrier system that is particularly useful for administration of sequences for therapy.
REFERENCES:
patent: 5756122 (1998-05-01), Thierry et al.
patent: 5827703 (1998-10-01), Deb et al.
Maher et al., Specific hybridization arrest of dihydrofolate reductase mRNA in vitro using antisense RNA or antisense oligonucleotides, Archives of Biochemistry and Biophysics, vol. 253 (1), pp. 214-220, Feb. 15, 1987.
Dritschilo Anatoly
Gokhale Prafulla
Kasid Usha
Rahman Aquilur
Georgetown University School of Medicine
Guzo David
Wang Andrew
LandOfFree
Liposomes containing oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposomes containing oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomes containing oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192545